Literature DB >> 22826866

Screening of siRNA nanoparticles for delivery to airway epithelial cells using high-content analysis.

Alan Hibbitts1, Nora Lieggi, Olive McCabe, Warren Thomas, James Barlow, Fiona O'Brien, Sally-Ann Cryan.   

Abstract

AIMS: Delivery of siRNA to the lungs via inhalation offers a unique opportunity to develop a new treatment paradigm for a range of respiratory conditions. However, progress has been greatly hindered by safety and delivery issues. This study developed a high-throughput method for screening novel nanotechnologies for pulmonary siRNA delivery.
METHODOLOGY: Following physicochemical analysis, the ability of PEI-PEG-siRNA nanoparticles to facilitate siRNA delivery was determined using high-content analysis (HCA) in Calu-3 cells. Results obtained from HCA were validated using confocal microscopy. Finally, cytotoxicity of the PEI-PEG-siRNA particles was analyzed by HCA using the Cellomics multiparameter cytotoxicity assay.
CONCLUSION: PEI-PEG-siRNA nanoparticles facilitated increased siRNA uptake and luciferase knockdown in Calu-3 cells compared with PEI-siRNA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22826866     DOI: 10.4155/tde.11.73

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  5 in total

Review 1.  siRNA delivery to the lung: what's new?

Authors:  Olivia M Merkel; Israel Rubinstein; Thomas Kissel
Journal:  Adv Drug Deliv Rev       Date:  2014-06-05       Impact factor: 15.470

Review 2.  Cell-Based Assay Design for High-Content Screening of Drug Candidates.

Authors:  Gregory Nierode; Paul S Kwon; Jonathan S Dordick; Seok-Joon Kwon
Journal:  J Microbiol Biotechnol       Date:  2016-02       Impact factor: 2.351

3.  In Vitro and In Vivo Assessment of PEGylated PEI for Anti-IL-8/CxCL-1 siRNA Delivery to the Lungs.

Authors:  Alan J Hibbitts; Joanne M Ramsey; James Barlow; Ronan MacLoughlin; Sally-Ann Cryan
Journal:  Nanomaterials (Basel)       Date:  2020-06-27       Impact factor: 5.076

4.  Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology.

Authors:  Paul J McKiernan; Orla Cunningham; Catherine M Greene; Sally-Ann Cryan
Journal:  Int J Nanomedicine       Date:  2013-10-11

5.  Identification of siRNA delivery enhancers by a chemical library screen.

Authors:  Jerome Gilleron; Prasath Paramasivam; Anja Zeigerer; William Querbes; Giovanni Marsico; Cordula Andree; Sarah Seifert; Pablo Amaya; Martin Stöter; Victor Koteliansky; Herbert Waldmann; Kevin Fitzgerald; Yannis Kalaidzidis; Akin Akinc; Martin A Maier; Muthiah Manoharan; Marc Bickle; Marino Zerial
Journal:  Nucleic Acids Res       Date:  2015-07-28       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.